Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies

PURPOSE: There is currently no standard chemotherapy regimen for patients with lymphoid malignancies being considered for reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation (RIC-alloHSCT). The ideal regimen would provide disease control and result in lymphocyte depleti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Salit, Rachel B., Fowler, Daniel H., Wilson, Wyndham H., Dean, Robert M., Pavletic, Steven Z., Dunleavy, Kieron, Hakim, Frances, Fry, Terry J., Steinberg, Seth M., Hughes, Thomas E., Odom, Jeanne, Bryant, Kelly, Gress, Ronald E., Bishop, Michael R.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2012
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295571/
https://ncbi.nlm.nih.gov/pubmed/22312100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.0296
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki